ReviewJournal of rheumatic diseases2026
Non-specific cutaneous lupus erythematosus and clinical significance: a literature review.
Review in Journal of rheumatic diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous lupus erythematosus (CLE) is classified into LE-specific cutaneous lesions and LE-non-specific cutaneous lesions. LE-specific lesions, which include acute cutaneous LE, sub-acute cutaneous LE, and chronic cutaneous LE have been well-described and studied regarding their association with systemic lupus erythematosus (SLE) and disease activity. Non-specific CLE is divided into thrombogenic (vascular), neutrophilic, or uncertain pathogenesis. Some features such as Raynaud, vasculitis, and alopecia have been well-documented with reported association with other clinical features of SLE and its disease activity. Still, some are under-recognized and not well-studied for their correlation with SLE disease activity, or clinical significance concerning SLE. This review aims to encompass each non-specific CLE and its clinical relevance in SLE. However, the literature was limited in many non-specific LE conditions with the lack of statistical evidence to prove its correlation to SLE or other signs and symptoms of SLE, including morbidity and mortality. Future research can provide predictions of the disease based on non-specific CLE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.